Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EFFECT: Empagliflozin on Platelet Function in Diabetic Patients
NCT04342819Phase 3Completed
- Sponsor
- The University of the West Indies
- Start
- Jan 2020
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of empagliflozin in type 2 diabetes mellitus (T2DM), sponsored by The University of the West Indies. Started Jan 2020; status: completed.
02
Drugs
empagliflozin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT04342819.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04342819.